CompoAtlas

FastaCare Prostate Health Capsule

Natural health product licensed in Canada

Licence holder
Fastacare Therapeutics Inc.
NPN or DIN-HM
80077964
Status
Active licence
Licence date
1 June 2017
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Urtica dioica

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 15:1

Dry plant equivalent : 2,250 milligramme

Potency : 70 % Ethanol

150 milligrammeNot calculated
Zinc

Source : Citrate de zinc

7.5 milligramme15,000 µg
Prunus africana

Source : Écorce (tige)

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 300 milligramme

Potency : 12 % Phytosterols

75 milligrammeNot calculated
Solanum lycopersicum

Source : Solanum lycopersicum - Chair (fruit)

Extract : Matériel brut frais

Extraction ratio : 4:1

Dry plant equivalent : 600 milligramme

Potency : 10 % Lycopene

150 milligrammeNot calculated
Serenoa repens

Source : Serenoa repens - fruit

Extract : Matériel brut sec

Extraction ratio : 4:1

Dry plant equivalent : 640 milligramme

Potency : 70 % Fatty acids

160 milligrammeNot calculated
Vitamine E

Source : Acétate de d-alpha-tocophéryle

16.75 ATNot calculated

Non-medicinal ingredients

Huile de graine de citrouille, Gélatine

PopulationAgeQuantity per servingFrequency
Adultes de sexe masculinNot specifiedminimum: 1 Capsule ; maximum: 1 Capsuleminimum: 2 days ; maximum: 2 days

Uses authorised in Canada

Helps to support prostate health. Helps reduce the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and nighttime urination) associated with benign prostatic hyperplasia. Saw Palmetto is used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Urtica dioica (root) is used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). Provides antioxidants for the maintenance of good health. Helps to maintain healthy skin. Helps the body to metabolize carbohydrates. Helps in connective tissue formation. Helps to maintain immune function. A factor in the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80077964

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line